ProxyBio, Inc.

A significant challenge in cancer drug discovery is that the best drug leads are missed due to the limitations of compound screening platforms. Additionally, when it comes to treating patients, the most effective treatment must be precise and personalized. At ProxyBio, our technology helps pharmaceutical companies and physicians identify the most effective therapies by leveraging patient-derived disease “proxies." Our platform makes it possible to reliably test thousands of drugs in parallel. At ProxyBio, we desire to ignite a paradigm shift in medicine by transforming how therapeutics are discovered and tailored to the right patients.